What Happened to Expanded Access to New Medicines?

Professional doctors and patients in a virtual environment

It is the true hybrid of clinical research and clinical care. A way of providing treatment-use or preventative-use access to groups of people in the target population who cannot participate in clinical trials, Expanded Access is important for doctors and patients who have the greatest unmet needs. Expanded Access Programs (EAPs) can also generate valuable […]